Arcutis Biotherapeutics Inc (ARQT)
R&D Expense Growth
-33.54%
Quarterly · Period ending:
ARQT R&D Expense Growth
Latest reported-33.54%period ending
Latest reported-33.54%period ending
ARQT Quarterly R&D Growth (QoQ) (0.00% → -33.54%)
Latest values, visible window
High-resolution chart · PNG
ARQT r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -33.539% | |
| 49.758% | |
| 4.3205% | |
| 0.7762% | |
| 10.8875% | |
| 21.1533% | |
| -25.7474% | |
| 1.0519% | |
| -16.6069% | |
| -2.6667% | |
| -9.3802% | |
| 4.0327% | |
| -28.649% | |
| 4.3333% | |
| -51.4176% | |
| 82.518% | |
| -5.95% | |
| -22.7101% | |
| 29.4404% | |
| 31.9811% | |
| 42.2264% | |
| -20.9798% | |
| -16.3974% | |
| 9.1106% | |
| 19.1685% | |
| 134.0987% | |
| -12.8847% | |
| 71.1672% | |
| 16.2986% | |
| 16.009% | |
| -24.4881% | |
| 156.9303% | |
| 0% | |
| 0% |